Literature DB >> 17041932

Trismus-pseudocamptodactyly syndrome is caused by recurrent mutation of MYH8.

Reha M Toydemir1, Harold Chen, Virginia K Proud, Rick Martin, Hans van Bokhoven, Ben C J Hamel, Joep H Tuerlings, Constantine A Stratakis, Lynn B Jorde, Michael J Bamshad.   

Abstract

Trismus-pseudocamptodactyly syndrome (TPS) is a rare autosomal dominant distal arthrogryposis (DA) characterized by an inability to open the mouth fully (trismus) and an unusual camptodactyly of the fingers that is apparent only upon dorsiflexion of the wrist (i.e., pseudocamptodactyly). TPS is also known as Dutch-Kentucky syndrome because a Dutch founder mutation is presumed to be the origin of TPS cases in the Southeast US, including Kentucky. To date only a single mutation, p.R674Q, in MYH8 has been reported to cause TPS. Several individuals with this mutation also had a so-called "variant" of Carney complex, suggesting that the pathogenesis of TPS and Carney complex might be shared. We screened MYH8 in four TPS pedigrees, including the original Dutch family in which TPS was reported. All four TPS families shared the p.R674Q substitution. However, haplotype analysis revealed that this mutation has arisen independently in North American and European TPS pedigrees. None of the individuals with TPS studied had features of Carney complex, and p.R674Q was not found in 49 independent cases of Carney complex that were screened. Our findings show that distal arthrogryposis syndromes share a similar pathogenesis and are, in general, caused by disruption of the contractile complex of muscle. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041932     DOI: 10.1002/ajmg.a.31495

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

Review 1.  Arthrogryposis: a review and update.

Authors:  Michael Bamshad; Ann E Van Heest; David Pleasure
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

2.  Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

Authors:  Fedik Rahimov; Oliver D King; Doris G Leung; Genila M Bibat; Charles P Emerson; Louis M Kunkel; Kathryn R Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

3.  Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies.

Authors:  Ann E Davidson; Fazeel M Siddiqui; Michael A Lopez; Peter Lunt; Heather A Carlson; Brian E Moore; Seth Love; Donald E Born; Helen Roper; Anirban Majumdar; Suman Jayadev; Hunter R Underhill; Corrine O Smith; Maja von der Hagen; Angela Hubner; Philip Jardine; Andria Merrison; Elizabeth Curtis; Thomas Cullup; Heinz Jungbluth; Mary O Cox; Thomas L Winder; Hossam Abdel Salam; Jun Z Li; Steven A Moore; James J Dowling
Journal:  Brain       Date:  2013-02       Impact factor: 13.501

4.  Defective sarcomere organization and reduced larval locomotion and fish survival in slow muscle heavy chain 1 (smyhc1) mutants.

Authors:  Siping Li; Haishen Wen; Shaojun Du
Journal:  FASEB J       Date:  2019-12-01       Impact factor: 5.191

5.  Myosin individualized: single nucleotide polymorphisms in energy transduction.

Authors:  Thomas P Burghardt; Kevin L Neff; Eric D Wieben; Katalin Ajtai
Journal:  BMC Genomics       Date:  2010-03-15       Impact factor: 3.969

6.  Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations.

Authors:  Homa Tajsharghi; Simon Hammans; Christopher Lindberg; Alexander Lossos; Nigel F Clarke; Ingrid Mazanti; Leigh B Waddell; Yakov Fellig; Nicola Foulds; Haider Katifi; Richard Webster; Olayinka Raheem; Bjarne Udd; Zohar Argov; Anders Oldfors
Journal:  Eur J Hum Genet       Date:  2013-11-06       Impact factor: 4.246

7.  Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.

Authors:  S A Boikos; A Horvath; S Heyerdahl; E Stein; A Robinson-White; I Bossis; J Bertherat; J A Carney; C A Stratakis
Journal:  Horm Metab Res       Date:  2008-05       Impact factor: 2.936

8.  Mutations in ECEL1 cause distal arthrogryposis type 5D.

Authors:  Margaret J McMillin; Jennifer E Below; Kathryn M Shively; Anita E Beck; Heidi I Gildersleeve; Jason Pinner; Gloria R Gogola; Jacqueline T Hecht; Dorothy K Grange; David J Harris; Dawn L Earl; Sujatha Jagadeesh; Sarju G Mehta; Stephen P Robertson; James M Swanson; Elaine M Faustman; Heather C Mefford; Jay Shendure; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2012-12-20       Impact factor: 11.025

9.  The embryonic myosin R672C mutation that underlies Freeman-Sheldon syndrome impairs cross-bridge detachment and cycling in adult skeletal muscle.

Authors:  Alice W Racca; Anita E Beck; Margaret J McMillin; F Steven Korte; Michael J Bamshad; Michael Regnier
Journal:  Hum Mol Genet       Date:  2015-03-03       Impact factor: 6.150

Review 10.  Models of Distal Arthrogryposis and Lethal Congenital Contracture Syndrome.

Authors:  Julia Whittle; Aaron Johnson; Matthew B Dobbs; Christina A Gurnett
Journal:  Genes (Basel)       Date:  2021-06-20       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.